CJC-1295 CAS:863288-34-0

CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life.

Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 日. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse.

CJC-1295 is an injectable peptide used to increase GH production. This peptide is a hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.

The principal use of CJC-1295 is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. Generally, a product in the GHRH category, including CJC-1295, is chosen as an alternate to using GH, and only rarely is combined with GH.

Dosage Amount:300mcg of CJC-1295/Ipamorelin daily

Dosage Frequency: 300mcg once daily or 150mcg twice daily

CJC-1295/Impamorelin should be taken daily for 12-16 weeks at a time

CJC-1295 take approximately 1-4 hours to reach peak serum levels, while Ipamorelin works quickly and is typically cleared out of the system rapidly as its half life is only about two hours.

Doses should be taken on an empty stomach, over one hour before and after eating.